FindTrial
Sign In

A clinical trial on assessing the accuracy of Non invasive Haemoglobin measurement in patients undergoing lower limb bone surgeries in reducing the unwarranted blood transfusions

Evaluation of efficacy of Non Invasive Haemoglobin Measurement (NIHM) in perioperative settings in Lower limb orthopedic surgeries : A Prospective randomised Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033548
Enrollment
320
Registered
2021-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S720- Fracture of head and neck of femur Health Condition 2: S724- Fracture of lower end of femur Health Condition 3: S723- Fracture of shaft of femur Health Condition 4: S721- Pertrochanteric fracture Health Condition 5: S722- Subtrochanteric fracture of femur

Interventions

Intervention1: Non invasive haemoglobin measurement to assess the need for blood transfusion: The need for blood transfusion will be assessed by non invasive hemoglobin measurement in the study group

Sponsors

Gopalakrishnan K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I & II patients undergoing orthopaedic femur surgeries.

Exclusion criteria

Exclusion criteria: Patients with known allergy to local anaesthetic drugs, Pregnant and lactating women, History of bleeding disorders/ coagulation defects, BMI : >35 and Patient refusal

Design outcomes

Primary

MeasureTime frame
Number of blood transfusions in each groupTimepoint: 6 hours—

Secondary

MeasureTime frame
Accuracy of Noninvasive haemoglobin when compared with laboratory tested valuesTimepoint: 6 hours—

Countries

India

Contacts

Public ContactGopalakrishnan K

Sri Lakshmi Narayana Institute of Medical Sciences

drkgpal73@gmail.com9364450310

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026